Bicycle Therapeutics (BCYC) Receivables (2018 - 2025)

Bicycle Therapeutics' Receivables history runs 8 years deep, the most recent figure standing at $35.6 million for Q4 2025.

• Quarterly Receivables changed 0.28% year-over-year to $35.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $35.6 million (changed 0.28% YoY) and the FY2025 annual result came in at $35.6 million, changed 0.28% from the prior year.
• Receivables was $35.6 million for Q4 2025 at Bicycle Therapeutics, down from $46.4 million in the prior quarter.
• Across five years, Receivables topped out at $76.5 million in Q1 2023 and bottomed at $1.0 million in Q4 2021.
• A 5-year average of $31.8 million and a median of $26.3 million in 2022 frame the typical range for Receivables.
• Annual changes were most pronounced in 2021 — Receivables slumped 81.67% — and 2022, when it surged 2020.7%.
• Bicycle Therapeutics' Receivables stood at $1.0 million in 2021, then jumped by 2020.7% to $21.2 million in 2022, then climbed by 13.35% to $24.0 million in 2023, then soared by 48.51% to $35.7 million in 2024, then retreated by 0.28% to $35.6 million in 2025.
• Business Quant data shows BCYC's Receivables at $35.6 million in Q4 2025, $46.4 million in Q1 2025, and $35.7 million in Q4 2024.